OssDsign AB

OssDsign AB
About Us
Contacts
Change country

Follow us:
Share:
Subscribe:

About Us

OssDsign is a developer and global provider of next generation bone replacement products. Based on cutting edge material science, the company develops and markets products that support the body's own healing capabilities and thereby improve the clinical outcome in a wide range of orthopedic areas with high medical needs. With a product portfolio consisting of patient-specific implants for cranial surgeries and an off-the-shelf synthetic bone graft for spine surgeries, OssDsign give patients back the life they deserve. The company has a strong commercial presence in the U.S., Europe and selected Asian countries. OssDsign's share is traded on Nasdaq First North Growth Market in Stockholm, Sweden.

Contacts

Morten Henneveld

CEO

+46 18 55 39 93
morten.henneveld@ossdsign.com

OssDsign AB (publ) publishes Q2 2024 Interim Report

Tue, Aug 20, 2024 07:00 CET

Reaching milestone in orthobiologics salesOssDsign AB (publ) announces that the interim report for Q2 2024 is now available as a PDF on the company’s website www.ossdsign.com/reports. A PDF version is also attached to this press release.The Q2 2024 results will also be presented at an investor webcast today August 20th at 11:00 CET. The webcast can be accessed via the following link: www.finwire.tv/webcast/ossdsign/q2-2024/ or via the OssDsign website. The second quarter in figures · Net sales amounted to TSEK 29,737 (23,997), corresponding to a growth of 143%, or 139%

There are no items matching the current filter

There are no more items matching the current filter

About Us

Contacts

Links

OssDsign AB (publ) publishes Q2 2024 Interim Report

Subscribe

Media

Share

About Us

Contacts

Links

OssDsign AB (publ) publishes Q2 2024 Interim Report

Subscribe

Media